4 clinical trials found.
-
(Medley)-A Phase 2/3 Randomized Double-blind Palivizumab-controlled Study to Evaluate the Safety of MEDI8897 a Monoclonal Antibody With an Extended Half-life Against Respiratory Syncytial Virus in High-risk Children (MEDLEY)
In this study, MEDI8897 is being compared to Synagis® to determine if the effectiveness and safety of MEDI8897 is similar to Synagis®.MEDI8897 is a ...Phase
TRIAL ROLE: Sub Investigator
-
A Phase III Randomized Double-blind Placebo-controlled Multicenter Study in Adults to Determine the Safety Efficacy and Immunogenicity of AZD1222 a Non-replicating ChAdOx1 Vector Vaccine for the Prevention of COVID-19
The aim of the study is to assess the safety, efficacy, and immunogenicity of AZD1222 for the prevention of COVID-19. The COVID-19 pandemic has caused ...Phase
Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
A Phase 3 Randomized Double- Or Observer-Blinded Placebo-Controlled Trial to Evaluate the Efficacy and Safety of a Respiratory Syncytial Versus (RSV) Prefusion F Subunit Vaccine in Infants Born To Women Vaccinated During Pregnancy
The purpose of this study is to find out if Pfizer’s investigational RSVpreF vaccine prevents the development of RSV illness in your baby. A ...Phase
Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
-
MixNMatch COVID Booster Study - A Phase 1/2 Study of Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) after Receipt of EUA Vaccines (NIH / DMID)
This study is called MixNMatch because its purpose is to learn about the safety, side effects, and immune response of mixing (heterologous) or matching (homologous ...Phase
Accepts Healthy Volunteer
TRIAL ROLE: Sub Investigator
